Neumora Therapeutics Faces Delisting Concerns
Ticker: NMRA · Form: 8-K · Filed: May 16, 2025 · CIK: 1885522
| Field | Detail |
|---|---|
| Company | Neumora Therapeutics, INC. (NMRA) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Neumora's in hot water - might get delisted!
AI Summary
Neumora Therapeutics, Inc. filed an 8-K on May 16, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the effective date of the event being May 14, 2025. The company, formerly known as RBNC Therapeutics, Inc., is incorporated in Delaware and headquartered in Watertown, Massachusetts.
Why It Matters
This filing indicates potential issues with Neumora Therapeutics' continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a severe event that directly threatens the company's public trading status.
Key Players & Entities
- Neumora Therapeutics, Inc. (company) — Registrant
- May 14, 2025 (date) — Earliest event reported
- May 16, 2025 (date) — Filing date
- RBNC Therapeutics, Inc. (company) — Former company name
- Watertown, Massachusetts (location) — Principal executive offices
FAQ
What specific listing rule or standard has Neumora Therapeutics, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that has not been met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the expected timeline for the delisting process, if it proceeds?
The filing does not provide a specific timeline for the delisting process; it only reports the date of the event as May 14, 2025.
Has Neumora Therapeutics, Inc. taken any steps to rectify the situation that led to this notice?
The provided text of the 8-K filing does not contain information regarding any steps taken by Neumora Therapeutics, Inc. to rectify the situation.
What exchange is Neumora Therapeutics, Inc. listed on?
The filing does not explicitly state the exchange on which Neumora Therapeutics, Inc. is listed.
What was the former name of Neumora Therapeutics, Inc. and when did the name change occur?
The former name of Neumora Therapeutics, Inc. was RBNC Therapeutics, Inc., and the date of the name change was September 29, 2021.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding Neumora Therapeutics, Inc. (NMRA).